MANAGEMENT OF MYELOFIBROSIS WITH INTERMITTENT HYDROXYUREA

被引:40
作者
MANOHARAN, A
机构
[1] Department of Clinical Haematology, St George Hospital, University of New South Wales, Sydney, New South Wales, 2217, Kogarah
关键词
D O I
10.1111/j.1365-2141.1991.tb07989.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:252 / 259
页数:8
相关论文
共 8 条
[1]   REMISSION OF CHRONIC IDIOPATHIC MYELOFIBROSIS TO BUSULFAN TREATMENT [J].
CHANG, JC ;
GROSS, HM .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1988, 295 (05) :472-476
[2]   PROCOLLAGEN TYPE-III AMINOTERMINAL PEPTIDE IN SERUM IN IDIOPATHIC MYELOFIBROSIS AND ALLIED CONDITIONS - RELATION TO DISEASE-ACTIVITY AND EFFECT OF CHEMOTHERAPY [J].
HASSELBALCH, H ;
JUNKER, P ;
HORSLEVPETERSEN, K ;
LISSE, I ;
BENTSEN, KD .
AMERICAN JOURNAL OF HEMATOLOGY, 1990, 33 (01) :18-26
[3]  
KAPLAN ME, 1986, SEMIN HEMATOL, V23, P167
[4]  
LOFVENBERG E, 1990, EUR J HAEMATOL, V44, P33
[5]  
MANOHARAN A, 1988, EUR J HAEMATOL, V40, P149
[6]   MYELOFIBROSIS - PROGNOSTIC FACTORS AND TREATMENT [J].
MANOHARAN, A .
BRITISH JOURNAL OF HAEMATOLOGY, 1988, 69 (03) :295-298
[7]  
MANOHARAN A, 1984, SCAND J HAEMATOL, V33, P453
[8]  
SILVER RT, 1990, SEMIN HEMATOL, V27, P6